Neuland Laboratories share news and announcements
NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap
Last close ₹18,865.00down ₹70.00 (0.37%)BSE ₹18,924.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹18,935.00.
52-week range of traded prices to 23 Oct 2026
₹11,500.00Low, 23 Mar 2026₹24,225.00High, 9 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹24,204 Cr356th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 5 Aug 2026
- 48.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 12.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.18%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 5 Aug 2026
- 29.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 32.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 53,34748.3% delivered
Neuland Laboratories routine notices
176 filed, newest first. Page 3 of 4.
Feb 2023
14 Feb · Routine
14 Feb · Routine
1 Feb · Routine
Jan 2023
Dec 2022
Nov 2022
21 Nov · Routine
Sep 2022
28 Sep · Routine
Aug 2022
Jul 2022
9 Jul · Routine
Jun 2022
29 Jun · Routine
11 Jun · Routine
8 Jun · Routine
May 2022
11 May · Routine
Mar 2022
30 Mar · Routine
28 Mar · Routine
11 Mar · Routine
Feb 2022
2 Feb · Routine
Jan 2022
12 Jan · Routine
7 Jan · Routine
Dec 2021
30 Dec · Routine
Nov 2021
29 Nov · Routine
1 Nov · Routine
Oct 2021
Sep 2021
Aug 2021
4 Aug · Routine
Jul 2021
Jun 2021
15 Jun · Routine
9 Jun · Routine
May 2021
12 May · Routine
Apr 2021
28 Apr · Routine
16 Apr · Routine
Mar 2021
Feb 2021
3 Feb · Routine
Jan 2021
8 Jan · Routine
Dec 2020
5 Dec · Routine
4 Dec · Routine
Nov 2020